The detailed information for PTAB case with proceeding number IPR2015-00417 filed by Boehringer Ingelheim Pharmaceuticals, Inc. et al. against Genentech, Inc. on Dec 15, 2014. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2015-00417
Filing Date
Dec 15, 2014
Petitioner
Boehringer Ingelheim Pharmaceuticals, Inc. et al.
Respondent
Genentech, Inc.
Status
Terminated-Settled
Respondent Application Number
12052606
Respondent Tech Center
1600
Respondent Patent Number
7976838
Institution Decision Date
Jul 14, 2015
Termination Date
Oct 1, 2015

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Termination - Request for Adverse Judgment After Institution

Oct 1, 2015PAPERBOARD

Request for Adverse Judgment

Sep 29, 2015PAPERPETITIONER

Order - Conduct of the Proceeding - 37 CFR 42.5

Sep 25, 2015PAPERBOARD

Patent Owner's Notice of Deposition of Joachim Kalden

Sep 18, 2015PAPERPATENT OWNER

DECISION Motion for Pro Hac Vice Recognition of Mr. Gindler

Aug 20, 2015PAPERBOARD

Notice of Stipulation Extending Due Dates 1-4

Aug 20, 2015PAPERPATENT OWNER

Decision Institution of Inter Partes Review

Jul 14, 2015PAPERBOARD

Scheduling Order

Jul 14, 2015PAPERBOARD

Patent Owner Preliminary Response

Apr 15, 2015PAPERPATENT OWNER

Patent Owner Exhibit List

Apr 15, 2015PAPERPATENT OWNER

January 27, 2001 Interview Summary (App. 12/052,606)

Apr 15, 2015EXHIBITPATENT OWNER

Felson, D.T., et al., American College of Rheumatology Preliminary Definition of Improvement in Rheumatoid Arthritis, 38_6 Arthritis and Rheumatism (1995)

Apr 15, 2015EXHIBITPATENT OWNER

Declaration of Ronald F. van Vollenhoven (Dec. 14, 2011).

Apr 15, 2015EXHIBITPATENT OWNER

Maini, R. et al., Infliximab (chimeric anti-tumour necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate_a randomised phase III trial, 354 LANCET 1932, 1935 (1999)

Apr 15, 2015EXHIBITPATENT OWNER

Strand, V. et al., Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate, 159 Arch. Intern. Med. 2542, 2546 (Nov. 22, 1999)

Apr 15, 2015EXHIBITPATENT OWNER

Cohen, S.B. et al., A multicenter, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate, 63 Annals of Rheumatic

Apr 15, 2015EXHIBITPATENT OWNER

Cohen, S.B. et al., Rituximab for Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Therapy, 54(9) ARTHRITIS AND RHEUMATISM 2793 (2006)

Apr 15, 2015EXHIBITPATENT OWNER

Rituxan (rituximab) Prescribing Information (02_2010)

Apr 15, 2015EXHIBITPATENT OWNER

R van Vollenhoven et al., Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa - data from the STURE registry showing that switching tumour necrosis factor a blockers can make sense, 62 Ann. Rheum. Dis. 1195 (2003)

Apr 15, 2015EXHIBITPATENT OWNER

Annex B to Declaration of Ronald F. van Vollenhoven (October 15, 2010)

Apr 15, 2015EXHIBITPATENT OWNER

Rituxan (rituximab) Prescribing Information (02_2006).

Apr 15, 2015EXHIBITPATENT OWNER

Gremillion, R.B. and van Vollenhoven, R.F., Rheumatoid Arthritis_Designing and implementing a treatment plan, 103(2) Postgraduate Medicine, 103 (1998)

Apr 15, 2015EXHIBITPATENT OWNER

Genentech, Inc. Form 10-K For Period Ended 12/31/2008

Apr 15, 2015EXHIBITPATENT OWNER

Unopposed Motion for Pro Hac Vice Admission of David Gindler

Apr 2, 2015PAPERPATENT OWNER

Patent Owner Power of Attorney and Notice of Appearance of Additional Counsel

Mar 9, 2015PAPERPATENT OWNER

Power of Attorney

Jan 16, 2015PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Related Matters

Jan 16, 2015PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Notice of Filing Date Accorded to Petition

Jan 15, 2015PAPERBOARD

Power of Attorney

Dec 15, 2014PAPERPETITIONER

Power of Attorney

Dec 15, 2014PAPERPETITIONER

Petition for IPR of US Patent 7976838

Dec 15, 2014PAPERPETITIONER

Ex 1001

Dec 15, 2014EXHIBITPETITIONER

Ex 1002

Dec 15, 2014EXHIBITPETITIONER

Ex 1003

Dec 15, 2014EXHIBITPETITIONER

Ex 1004

Dec 15, 2014EXHIBITPETITIONER

Ex 1005

Dec 15, 2014EXHIBITPETITIONER

Ex 1006

Dec 15, 2014EXHIBITPETITIONER

Ex 1007

Dec 15, 2014EXHIBITPETITIONER

Ex 1008

Dec 15, 2014EXHIBITPETITIONER

Ex 1009

Dec 15, 2014EXHIBITPETITIONER

Ex 1010

Dec 15, 2014EXHIBITPETITIONER

Ex 1011

Dec 15, 2014EXHIBITPETITIONER

Ex 1012

Dec 15, 2014EXHIBITPETITIONER

Ex 1013

Dec 15, 2014EXHIBITPETITIONER

Ex 1014

Dec 15, 2014EXHIBITPETITIONER

Ex 1015

Dec 15, 2014EXHIBITPETITIONER

Ex 1016

Dec 15, 2014EXHIBITPETITIONER

Ex 1017

Dec 15, 2014EXHIBITPETITIONER

Ex 1018

Dec 15, 2014EXHIBITPETITIONER

Ex 1019

Dec 15, 2014EXHIBITPETITIONER

Ex 1020

Dec 15, 2014EXHIBITPETITIONER

Ex 1021

Dec 15, 2014EXHIBITPETITIONER

Ex 1022

Dec 15, 2014EXHIBITPETITIONER

Ex 1023

Dec 15, 2014EXHIBITPETITIONER

Ex 1024

Dec 15, 2014EXHIBITPETITIONER

Ex 1025

Dec 15, 2014EXHIBITPETITIONER

Ex 1026

Dec 15, 2014EXHIBITPETITIONER

Ex 1027

Dec 15, 2014EXHIBITPETITIONER

Ex 1028

Dec 15, 2014EXHIBITPETITIONER

Ex 1029

Dec 15, 2014EXHIBITPETITIONER

Ex 1030

Dec 15, 2014EXHIBITPETITIONER

Ex 1031

Dec 15, 2014EXHIBITPETITIONER

Ex 1032

Dec 15, 2014EXHIBITPETITIONER

Ex 1033

Dec 15, 2014EXHIBITPETITIONER

Ex 1034

Dec 15, 2014EXHIBITPETITIONER

Ex 1035

Dec 15, 2014EXHIBITPETITIONER

Ex 1036

Dec 15, 2014EXHIBITPETITIONER

Ex 1037

Dec 15, 2014EXHIBITPETITIONER

Ex 1038

Dec 15, 2014EXHIBITPETITIONER

Ex 1039

Dec 15, 2014EXHIBITPETITIONER